News Breaks |
|
|
| March 17, 2013 |
| 22:12 EDT |  | ZTS, PFE | Zoetis has good outlook but stock looks too expensive, Barron's says Pfizer's (PFE) animal-health spin-off, Zoetis (ZTS), may be fully valued and investors should wait for a better opportunity to get in, Barron's argues. Reference Link |
|
|
News For ZTS;PFE From The Last 14 Days Check below for free stories on ZTS;PFE the last two weeks. |
|
|
| May 24, 2013 |
| 12:15 EDT |  | ZTS | Options with increasing implied volatility: MTG ZTS EWJ DXJ
Subscribe for More Information |
|
| 11:16 EDT |  | ZTS | High option volume stocks: ORIG CVA ZTS DOV CENX
Subscribe for More Information |
|
| 05:59 EDT |  | ZTS | Zoetis implied volatility at upper end of index mean range
Subscribe for More Information |
|
| May 23, 2013 |
| 12:37 EDT |  | ZTS | Options with increasing implied volatility: UNXL ZTS EWJ SWI
Subscribe for More Information |
|
| 11:24 EDT |  | ZTS | High option volume stocks: ZTS AMLP CTAS MNKD CYS
Subscribe for More Information |
|
| May 22, 2013 |
| 11:50 EDT |  | ZTS | High option volume stocks: ZTS AIRM GLDD GTXI MNKD
Subscribe for More Information |
|
| 08:59 EDT |  | PFE, ZTS | On The Fly: Pre-market Movers
Subscribe for More Information |
|
| 08:06 EDT |  | PFE, ZTS | Zoetis comments on Pfizer’s split-off plans for remaining interest
Subscribe for More Information |
|
| 08:04 EDT |  | PFE, ZTS | Pfizer announces plan to split-off remainder of Zoetis
Subscribe for More Information |
|
| 08:02 EDT |  | ZTS, PFE | Pfizer announces plan to split-off remainder of Zoetis
Subscribe for More Information |
| |
| May 21, 2013 |
| 07:16 EDT |  | PFE | Pfizer management to meet with Leerink
Subscribe for More Information |
|
| May 20, 2013 |
| 17:04 EDT |  | PFE | Pfizer discontinues phase 3 study of inotuzumab ozogamicin
Subscribe for More Information |
|
| May 16, 2013 |
| 08:55 EDT |  | PFE | BofA/Merrill's pharmaceuticals analysts hold analyst/industry conference call
Subscribe for More Information |
|
| 08:06 EDT |  | ZTS | Zoetis' Apoquel for allergic dogs approved by FDA Zoetis announced that the FDA has approved Apoquel (oclacitinib tablet) for the control of pruritus associated with allergic dermatitis and the control of atopic dermatitis in dogs at least 12 months of age. Pruritus, or itching, is the most common sign of allergies in dogs. |
|
|
|
|
|